Intensive research by organizations, Brain-Computer Interface (BCI) track heating up.

Wind data shows that as of February 26th when the reporter published the article, a total of 80 pharmaceutical and biotech industry listed companies have undergone institutional research this year. It is worth noting that companies in the brain-computer interface concept such as Xiangyu Medical, Aipeng Medical, and Meihao Medical have attracted the attention of many institutions for research, with focus on the development progress of brain-computer interface products, commercialization status, and future development plans. At the same time, the enthusiasm for innovative drugs going overseas has not diminished, with many pharmaceutical companies also receiving institutional attention. Industry insiders state that under the wave of AI technology, the pharmaceutical industry is expected to release new growth logic, continuing to favor the medical technology theme with innovation as the core, focusing on brain-computer interface, AI healthcare, and innovative drugs going overseas.